Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H14O |
| Molecular Weight | 150.2176 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C1=CC=C(O)C=C1C
InChI
InChIKey=IJALWSVNUBBQRA-UHFFFAOYSA-N
InChI=1S/C10H14O/c1-7(2)10-5-4-9(11)6-8(10)3/h4-7,11H,1-3H3
| Molecular Formula | C10H14O |
| Molecular Weight | 150.2176 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
O-Cymen-5-OL is an antifungal preservative used in cosmetics and beauty products to prevent harmful bacteria from developing and to prolong the shelf-life of formulas. It is part of the Isopropyl Cresols family and is originally developed synthetically in the form of a crystal. O-Cymen-5-OL is also used as a cosmetic biocide, or ingredient that helps to cleanse the skin or to prevent odor by destroying or inhibiting the growth of microorganisms, according to research. O-Cymen-5-OL is approved by the FDA for use as a direct and indirect food additive and has been approved by the CIR for use in cosmetics up to .5% concentration. However, in the European Union, it is only approved for use up to .1%. Studies in Japan, some dating back to 1956, found O-Cymen-5-OL to be neurotoxic in animals and have led to heavier restrictions on its use in cosmetics there. O-Cymen-5-OL (Dekasol BL) is used in oral care, to fight periodontal disease.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. | 2006-11 |
|
| Final report on the safety assessment of sodium p-chloro-m-cresol, p-chloro-m-cresol, chlorothymol, mixed cresols, m-cresol, o-cresol, p-cresol, isopropyl cresols, thymol, o-cymen-5-ol, and carvacrol. | 2006 |
Sample Use Guides
O-Cymen-5-OL has been approved by the CIR for use in cosmetics up to .5% concentration.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21762153
Curator's Comment: o-Cymen-5-ol minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined against Streptococcus mutans, Actinomyces viscosus, Porphyromonas gingivalis, Fusobacterium nucleatum and Candida albicans.
o-Cymen-5-ol MIC was between 1.7 mM to 3.4 mM; MBC was 3.4 mM to 6.7 mM.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:08:17 GMT 2025
by
admin
on
Mon Mar 31 18:08:17 GMT 2025
|
| Record UNII |
H41B6Q1I9L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
221-761-7
Created by
admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
|
PRIMARY | |||
|
DTXSID10186026
Created by
admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
|
PRIMARY | |||
|
H41B6Q1I9L
Created by
admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
|
PRIMARY | |||
|
100000132789
Created by
admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
|
PRIMARY | |||
|
SUB48260
Created by
admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
|
PRIMARY | |||
|
C512394
Created by
admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
|
PRIMARY | |||
|
H41B6Q1I9L
Created by
admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
|
PRIMARY | |||
|
62111
Created by
admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
|
PRIMARY | |||
|
3228-02-2
Created by
admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
|
PRIMARY | |||
|
18597
Created by
admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
|
PRIMARY | |||
|
1364387
Created by
admin on Mon Mar 31 18:08:17 GMT 2025 , Edited by admin on Mon Mar 31 18:08:17 GMT 2025
|
PRIMARY | RxNorm |